comparemela.com

Latest Breaking News On - Dr reddys laboratories - Page 1 : comparemela.com

Patent Infringement In India: Recent Case Studies And Legal Updates

Patent infringement occurs when someone uses, makes, sells, or imports a patented invention without the permission of the patent owner. It is a serious matter because it undermines the rights of.

Q4 results today: PB Fintech, Dr Reddy s among 43 companies to announce results

43 companies are set to announce Q4 results, with Dr Reddy s and PB Fintech in focus. Dr Reddy s eyes revenue and net profit growth, while PB Fintech anticipates 18% YoY growth in core business premium.

Dr Reddy s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

Dr Reddy s Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore.​​

Three stocks that can deliver up to 10% in the short term; watch out for the rising VIX

The volatility index (VIX) bouncing back suggests challenges ahead, while on the downside, a breach below 22,300 could lead to a slide towards 22,100–22,000 on the Nifty.

Dr Reddy s Q4 Preview: PAT may rise over 50% YoY on strong US sales

According to an average estimate of four brokerages, revenue from operations in the January-March 2023 period is seen growing up to 18% year-on-year. Meanwhile, net profit after tax is likely to surge up to 54% YoY.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.